Infarct Size Following Treatment With Second‐ Versus Third‐Generation P2Y 12 Antagonists in Patients With Multivessel Coronary Disease at ST‐Segment Elevation Myocardial Infarction in the CvLPRIT Study-Reference-Cited by-同舟云学术

Infarct Size Following Treatment With Second‐ Versus Third‐Generation P2Y 12 Antagonists in Patients With Multivessel Coronary Disease at ST‐Segment Elevation Myocardial Infarction in the CvLPRIT Study

Published:2016-06-13 Issue:6 Volume:5 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Khan Jamal N.¹²,Greenwood John P.³,Nazir Sheraz A.¹²,Lai Florence Y.¹²,Dalby Miles⁴,Curzen Nick⁵,Hetherington Simon⁶,Kelly Damian J.⁷,Blackman Daniel³,Peebles Charles⁵,Wong Joyce⁴,Flather Marcus⁸,Swanton Howard⁹,Gershlick Anthony H.¹²,McCann Gerry P.¹²

Affiliation:

1. Department of Cardiovascular Sciences, University of Leicester, UK

2. NIHR Leicester Cardiovascular Biomedical Research Unit, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK

3. Multidisciplinary Cardiovascular Research Centre & The Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK

4. Royal Brompton and Harefield Foundation Trust, Harefield Hospital, Middlesex, UK

5. University Hospital Southampton NHS Foundation Trust and University of Southampton, UK

6. Kettering General Hospital, Kettering, UK

7. Royal Derby Hospital, Derby, UK

8. Norfolk and Norwich University Hospitals NHS Foundation Trust and Norwich Medical School, University of East Anglia, Norwich, UK

9. The Heart Hospital, University College London Hospitals, London, UK

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

2. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

3. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

4. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

5. Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of microvascular obstruction and intramyocardial hemorrhage in reperfusion injury to the heart;Сибирский научный медицинский журнал;2024-04-26

2. The Role of Microvascular Obstruction and Intra-Myocardial Hemorrhage in Reperfusion Cardiac Injury. Analysis of Clinical Data;Reviews in Cardiovascular Medicine;2024-03-14

3. Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction;Nature Reviews Cardiology;2023-11-24

4. The role of platelet P2Y₁₂ receptors in inflammation;British Journal of Pharmacology;2023-11-02

5. What do we know about platelets in myocardial ischemia-reperfusion injury and why is it important?;Thrombosis Research;2023-09